---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-023853"
form_type: "8-K"
ticker: "LFMD"
cik: "0000948320"
company_name: "LifeMD, Inc."
filed_at: "2025-11-17T23:59:59+00:00"
generated_at: "2026-05-16T19:36:16.526970+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.78
calibrated_materiality_score: 0.78
confidence: "high"
source: SEC EDGAR
---

# LifeMD Q3 revenue $60.2M (+13%), adj EBITDA $5.1M; paid off debt, sold WorkSimpli

## Summary
- Total revenue $60.2M (+13% YoY); adjusted EBITDA $5.1M (+20% YoY).
- Telehealth revenue $47.3M (+18% YoY); telehealth adjusted EBITDA $2.9M (+30% YoY).
- Paid off all outstanding debt in Q3; divested majority stake in WorkSimpli after quarter end.
- Pennsylvania 503-A compounding pharmacy approved; licensed in 14 states, pursuing 50-state license.
- RexMD added nearly 10,000 net new subscribers; strong early traction in behavioral, women's, men's health.

## SEC filing metadata
- accession: 0001493152-25-023853
- form_type: 8-K
- ticker: LFMD
- cik: 0000948320
- company_name: LifeMD, Inc.
- filed_at: 2025-11-17T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.78
- calibrated_materiality_score: 0.78
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/948320/000149315225023853/0001493152-25-023853-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/948320/000149315225023853/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-023853
- JSON: https://secwatch.observer/filing/0001493152-25-023853.json
- Plain text: https://secwatch.observer/filing/0001493152-25-023853.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.